The clinical management of moderate to moderately severe pain frequently involves centrally acting analgesics designed to modulate nociceptive pathways within the central nervous system. Across international healthcare jurisdictions spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, clinicians and patients regularly evaluate the precise dosing parameters […]